Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Oxybutynin Versus Paroxetine in Breast Cancer Patients With Aromatase Inhibitor-induced Vasomotor Symptoms.

NCT05637671 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT05637671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05637671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Oxybutynin Versus Paroxetine in Breast Cancer Patients With Aromatase Inhibitor-induced Vasomotor Symptoms.
Lead sponsor
Cairo University
Phase
Phase 3
Overall status
Unknown status
Start date
February 10, 2022
Completion date
December 31, 2023
Enrollment
146 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vasomotor symptoms